January 3, 2007 (Paris, France) - A new genetic study investigating the distribution of alleles for long-QT syndrome has shown there is transmission distortion, resulting in a skewed segregation of ...

Repolarization abbreviation with the antiarrhythmic drug mexiletine has been found to normalize the QTc interval and reduce the rate of events in long QT syndrome type 3 (LQT3), but it is only ...

Less than 1 percent of the population has been diagnosed with Long QT syndrome – a rare heart condition that can cause chaotic, sometimes fatal, heart rhythms. Now, Virginia Tech researchers at the ...

Please provide your email address to receive an email when new articles are posted on . “Previous studies have shown that the risk of cardiac events is significantly increased in [long QT syndrome] ...

A machine learning model was more effective at detecting congenital long QT syndrome on resting ECGs than manual measurement of QT intervals by arrhythmia experts, in a new study. Researchers ...

Congenital long QT syndrome (LQTS), a rare cardiac disorder, is associated with syncope, and with sudden cardiac death from ventricular arrhythmias. Inheritance is predominantly autosomal dominant, ...

Jervell and Lange Nielsen syndrome (JLNS) is a rare cardio-auditory disorder with an autosomal recessive pattern of inheritance. JLNS was first reported in Norway in 1957. Bilateral sensorineural ...

Please provide your email address to receive an email when new articles are posted on . In long QT syndrome, patients doing vigorous exercise did not have more events than those doing nonvigorous ...

Phase 2/3 Wave II Clinical Study to Begin in 2026 Completion of Financing to Support Registration Program MONTREAL, Sept. 17, 2025 /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology ...

Long QT Syndrome: Completion of dosing in the WAVE-1 drug induced Long QT Syndrome study enables enrollment of in-patient, safety cohort of Long QT Syndrome patients. Oncology: New in vivo data with ...

Women with congenital long QT syndrome (LQTS) need to be cautious when taking an oral contraceptive (OC), observational data suggest—those on progestin-only pills are nearly three times more likely to ...

MONTREAL, Sept. 17, 2025 /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for cardiovascular diseases, ...